Showing 1021-1030 of 1092 results for "".
- Vic A Narurkar, MD: Remembering a Legendhttps://modernaesthetics.com/news/vic-a-narurkar-md-remembering-a-legend/2471955/The dermatology community lost a true rock star with the sudden passing of Vic A Narurkar MD, FAAD in late January. Loved by so many, Dr. Narurkar was the Founder of the Bay Area Laser Institute in San Francisco and a past president of the American Society of Cosmetic Derma
- AAFPRS 2018 Stats: Rhinoplasty Reigns Supreme, Millennials Are The New Influencers, Plus Morehttps://modernaesthetics.com/news/aafprs-2018-stats-rhinoplasty-reigns-supreme-millennials-are-the-new-influencers-plus-more/2471961/Seventy-two percent of facial plastic surgeons saw an increase in cosmetic surgery or injectables in patients under age 30 in 2018, a significant increase from 2017, where over half of members noted this influx of younger patients, according to the latest statistics from the
- Revance Shares Positive Efficacy and Duration Data for RT002https://modernaesthetics.com/news/revance-share-positive-efficacy-and-duration-data-for-rt002/2471986/Revance Therapeutics, Inc.'s long-acting neuromodulator daxibotulinumtoxinA for Injection (RT002) with its proprietary stabilizing excipient peptide technology delivered positive top-line results in alleviating moderate to severe glabellar lines in the SAKURA 3 Phase 3 open-label, long-term s
- Sinclair Pharma: Acquisition by Huadong Medicine Company Limited Now Completehttps://modernaesthetics.com/news/sinclair-pharma-acquisition-by-huadong-medicine-company-limited-now-complete/2471988/Huadong Medicine Company Limited (HMC) has acquired Sinclair Pharma Limited, a global aesthetics company headquartered in London, UK, in a deal worth approximately $222 million. HMC is a well-known Chinese pharmaceutical listed company that has established a leading aesthetics business in China a
- ISAPS 2017: US Still Reigns As Cosmetic Surgery Capitol of the Worldhttps://modernaesthetics.com/news/isaps-2017-us-still-reigns-as-cosmetic-surgery-capitol-of-the-world/2471994/The USA, Brazil, Japan, Italy and Mexico continue to perform the most cosmetic surgery procedures across the globe, according to the 2017 statistics from the International Society of Aesthetic Plastic Surgery (ISAPS). These top five countries account f
- Scott Peterson, PhD is Now Head of Medical Affairs at Evolushttps://modernaesthetics.com/news/scott-peterson-phd/2472004/R. Scott Peterson, PhD is now Head of Medical Affairs at Evolus, supporting the strategic development and execution of medical affairs initiatives. Evolus is a company dedicated to aestheti
- Bellus Recognized with Multiple Aesthetic Awardshttps://modernaesthetics.com/news/bellus-recognized-with-multiple-aesthetic-awards/2472006/Bellus Medical topped the charts in eight categories presented by the 2018 Aesthetic Everything® Awards: · Top Aesthetic Companies · Top Skin Care Devices (SkinPen&r
- ARTAS iX: Real-World Evaluation Study Shows Benefithttps://modernaesthetics.com/news/artas-ix-real-world-evaluation-study-shows-benefit/2472009/Restoration Robotics, Inc. (NASDAQ: HAIR), the global leader in robotic hair restoration, today announced results from a real-world evaluation study of The new ARTAS iX™ Robotic Hair Restoration System demonstrates clinical efficiency in hair harvesting and implan
- Galderma Launches "Face Your Hands" Campaign with Celebrity Manicuristhttps://modernaesthetics.com/news/galderma-launches-face-your-hands-campaign-with-celebrity-manicurist/2472030/Galderma Laboratories, L.P.,’s Restylane® Lyft is partnering with celebrity manicurist Deborah Lippmann for the "Face Your Hands" campaign, which aims to educate women on the steps they can take to achieve more youthful hands. A
- New for EBD-Based Acne Care: Sebacia Microparticles Clearedhttps://modernaesthetics.com/news/new-for-ebd-based-acne-care-sebacia-microparticles-cleared/2472033/Sebacia Microparticles are now FDA-cleared for use in the treatment of acne. The clearance comes on the heels of a pivotal study demonstrating the clinical safety and efficacy of the micoparticles. Sebacia, Inc. had submitted its 510(k) submission to the FDA in June 2018. Sebacia Mic